Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Jill Slansky

Concepts (322)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Cancer Vaccines
14
2021
172
2.780
Why?
Receptors, Antigen, T-Cell
15
2023
718
2.490
Why?
CD8-Positive T-Lymphocytes
19
2024
900
2.420
Why?
Antigens, Neoplasm
13
2023
319
1.960
Why?
Neoplasms
13
2023
2671
1.920
Why?
T-Lymphocytes
14
2023
1996
1.870
Why?
Lymphocytes, Tumor-Infiltrating
5
2023
210
1.680
Why?
Vaccines, Subunit
4
2013
49
1.170
Why?
T-Lymphocytes, Cytotoxic
7
2022
173
0.970
Why?
Peptides
8
2023
985
0.960
Why?
Granzymes
2
2024
50
0.950
Why?
Epitopes, T-Lymphocyte
6
2012
181
0.910
Why?
Mice, Inbred BALB C
18
2021
1272
0.750
Why?
Leukemia
1
2024
240
0.730
Why?
Immunotherapy
8
2021
641
0.730
Why?
Lymphocyte Activation
11
2019
1142
0.700
Why?
Tumor Escape
3
2019
42
0.690
Why?
Baculoviridae
3
2009
44
0.650
Why?
Neoplasms, Experimental
2
2021
176
0.640
Why?
Tumor Microenvironment
7
2025
674
0.640
Why?
Antigen Presentation
6
2018
218
0.640
Why?
Immunogenetic Phenomena
1
2019
7
0.620
Why?
Immunomodulation
1
2020
98
0.620
Why?
Peptide Library
4
2013
92
0.610
Why?
Insecta
3
2009
67
0.590
Why?
Epitopes
2
2020
479
0.590
Why?
Histocompatibility Antigens Class I
6
2019
203
0.580
Why?
Major Histocompatibility Complex
4
2008
227
0.570
Why?
Animals
47
2025
36940
0.560
Why?
H-2 Antigens
5
2008
115
0.560
Why?
Mice
34
2025
17787
0.530
Why?
Alternative Splicing
1
2019
229
0.530
Why?
Gene Expression Regulation, Neoplastic
4
2019
1396
0.480
Why?
Autoimmunity
2
2020
908
0.470
Why?
Neoplasm Proteins
2
2018
434
0.450
Why?
Immune Tolerance
3
2025
363
0.450
Why?
Vaccines
2
2010
406
0.440
Why?
Colorectal Neoplasms
5
2019
806
0.440
Why?
Up-Regulation
3
2019
843
0.440
Why?
Antigens
3
2019
357
0.440
Why?
Breast Neoplasms
4
2025
2253
0.430
Why?
Cytotoxicity, Immunologic
6
2024
224
0.430
Why?
CD4-Positive T-Lymphocytes
3
2019
1091
0.400
Why?
Colonic Neoplasms
3
2012
258
0.390
Why?
Allergy and Immunology
1
2013
43
0.390
Why?
Complementarity Determining Regions
1
2012
51
0.380
Why?
B-Lymphocytes
1
2017
847
0.370
Why?
Antigenic Variation
1
2011
10
0.370
Why?
Moloney murine leukemia virus
1
2011
13
0.370
Why?
Viral Envelope Proteins
1
2011
84
0.350
Why?
B7-H1 Antigen
2
2025
217
0.320
Why?
Cell Cycle Proteins
6
1997
617
0.320
Why?
Carrier Proteins
6
1997
771
0.320
Why?
Histocompatibility Antigens
2
2020
105
0.320
Why?
DNA-Binding Proteins
9
2018
1502
0.300
Why?
Carcinoma, Non-Small-Cell Lung
1
2017
1081
0.300
Why?
Receptors, Antigen, T-Cell, alpha-beta
2
2022
336
0.290
Why?
Mice, Transgenic
6
2023
2167
0.290
Why?
Autoimmune Diseases
1
2012
460
0.280
Why?
Tetrahydrofolate Dehydrogenase
4
1997
23
0.280
Why?
Inflammation
4
2020
2837
0.270
Why?
Cross Reactions
2
2020
133
0.260
Why?
Vaccination
3
2010
1381
0.250
Why?
Liver Neoplasms
4
2020
786
0.250
Why?
Triple Negative Breast Neoplasms
2
2019
202
0.240
Why?
Lung Neoplasms
2
2017
2526
0.240
Why?
Flow Cytometry
6
2016
1178
0.230
Why?
Semaphorins
1
2025
32
0.230
Why?
Histocompatibility Antigens Class II
2
2003
367
0.230
Why?
Cell Line, Tumor
10
2025
3412
0.230
Why?
Antigens, CD
3
2025
521
0.220
Why?
Humans
36
2025
137585
0.220
Why?
Mammary Glands, Animal
1
2025
129
0.220
Why?
Disease Models, Animal
3
2021
4295
0.220
Why?
Graft Rejection
2
2007
624
0.210
Why?
Listeria monocytogenes
3
2011
126
0.200
Why?
Lymphocyte Count
4
2017
148
0.200
Why?
Models, Biological
1
2010
1783
0.200
Why?
Amino Acid Substitution
2
2020
307
0.190
Why?
Transcription Factors
6
1997
1719
0.190
Why?
Female
23
2025
73304
0.180
Why?
Aging
2
2011
1864
0.180
Why?
Base Sequence
7
2016
2181
0.180
Why?
Dendritic Cells
3
2014
483
0.180
Why?
Histocompatibility Antigen H-2D
4
2022
21
0.180
Why?
Receptor-CD3 Complex, Antigen, T-Cell
1
2000
9
0.170
Why?
Heterografts
1
2021
138
0.170
Why?
Antineoplastic Combined Chemotherapy Protocols
2
2020
1692
0.170
Why?
Cytoreduction Surgical Procedures
1
2020
63
0.170
Why?
Programmed Cell Death 1 Receptor
3
2019
249
0.160
Why?
Immune System
1
2021
177
0.160
Why?
Chemokines, CXC
1
2019
70
0.160
Why?
Gene Editing
1
2020
80
0.150
Why?
Bcl-2-Like Protein 11
1
2019
38
0.150
Why?
Chemotherapy, Adjuvant
1
2020
389
0.150
Why?
Nanotechnology
1
2020
125
0.150
Why?
Gene Transfer Techniques
1
2020
170
0.150
Why?
CRISPR-Cas Systems
1
2020
125
0.150
Why?
Interleukin-12
1
2019
121
0.150
Why?
Oligopeptides
1
2000
271
0.150
Why?
Mice, Knockout
5
2021
3015
0.150
Why?
Calcineurin
1
2019
108
0.150
Why?
Tryptophan Oxygenase
1
2018
34
0.150
Why?
Autoantigens
1
2021
430
0.140
Why?
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
1
2019
80
0.140
Why?
Genetic Therapy
1
2020
297
0.140
Why?
Mutation
5
2020
3958
0.140
Why?
Disease Susceptibility
1
2020
347
0.140
Why?
Neoadjuvant Therapy
1
2020
404
0.140
Why?
Promoter Regions, Genetic
5
1997
1250
0.140
Why?
Cell Line
2
2016
2847
0.140
Why?
Histone Deacetylase Inhibitors
1
2019
210
0.130
Why?
Immunodominant Epitopes
2
2010
27
0.130
Why?
Antigen-Presenting Cells
1
2017
156
0.130
Why?
Tryptophan
1
2018
183
0.130
Why?
Genetic Engineering
2
2009
93
0.130
Why?
Protein Tyrosine Phosphatases
1
2018
172
0.130
Why?
Transcriptional Activation
2
2018
378
0.130
Why?
Antineoplastic Agents, Immunological
1
2019
190
0.130
Why?
Sarcoidosis, Pulmonary
1
2017
83
0.130
Why?
Spodoptera
2
2021
40
0.130
Why?
Oligonucleotide Array Sequence Analysis
2
2016
767
0.130
Why?
Mononuclear Phagocyte System
1
2016
12
0.130
Why?
Emulsions
1
2016
53
0.130
Why?
Ligands
4
2018
664
0.130
Why?
Immunophenotyping
1
2017
318
0.120
Why?
High-Throughput Nucleotide Sequencing
2
2017
539
0.120
Why?
Lymph Nodes
2
2016
491
0.120
Why?
Gene Expression Regulation
4
2022
2607
0.120
Why?
Papillomavirus Infections
1
2019
325
0.120
Why?
Phagocytes
1
2016
101
0.120
Why?
Cell Separation
1
2016
318
0.120
Why?
Lung
3
2017
4060
0.120
Why?
T-Lymphocyte Subsets
4
2007
417
0.110
Why?
Gene Expression Regulation, Enzymologic
2
1993
283
0.110
Why?
Bronchoalveolar Lavage Fluid
1
2017
652
0.110
Why?
Ovarian Neoplasms
1
2020
565
0.110
Why?
Interferon-gamma
5
2011
789
0.110
Why?
Retinoblastoma-Binding Protein 1
6
1997
22
0.110
Why?
Polymerase Chain Reaction
2
2016
1062
0.110
Why?
E2F Transcription Factors
6
1997
60
0.110
Why?
Head and Neck Neoplasms
1
2019
606
0.110
Why?
Transcription Factor DP1
5
1997
21
0.100
Why?
Colorado
2
2013
4565
0.100
Why?
Prognosis
2
2020
4030
0.100
Why?
Gene Expression Profiling
2
2010
1774
0.100
Why?
Molecular Sequence Data
8
2006
2900
0.090
Why?
T-Lymphocytes, Regulatory
3
2012
385
0.090
Why?
Enzyme-Linked Immunosorbent Assay
2
2012
852
0.090
Why?
Transcription, Genetic
3
1997
1457
0.090
Why?
Lymphoma, B-Cell
1
2012
106
0.090
Why?
Hemangiosarcoma
1
2010
21
0.080
Why?
Universities
1
2013
433
0.080
Why?
Research
1
2013
451
0.080
Why?
Carcinoma
1
2011
240
0.080
Why?
Genes, MHC Class I
1
2009
35
0.080
Why?
Down-Regulation
1
2011
657
0.080
Why?
Mice, Inbred C57BL
5
2019
5757
0.080
Why?
Neovascularization, Pathologic
1
2010
301
0.080
Why?
Cross-Priming
1
2008
15
0.070
Why?
CD11c Antigen
1
2008
41
0.070
Why?
E2F1 Transcription Factor
4
1997
64
0.070
Why?
Adjuvants, Immunologic
1
2009
226
0.070
Why?
Protein Conformation
2
2003
934
0.070
Why?
Xenograft Model Antitumor Assays
2
2021
872
0.070
Why?
Cell Culture Techniques
1
2009
363
0.060
Why?
Intramolecular Oxidoreductases
1
2006
68
0.060
Why?
Hematopoietic Stem Cell Transplantation
2
2021
622
0.060
Why?
Biomarkers
1
2017
4149
0.060
Why?
RNA, Messenger
2
1994
2833
0.060
Why?
Melanoma, Experimental
1
2006
114
0.060
Why?
Drug Design
1
2006
167
0.060
Why?
DNA Primers
1
2006
515
0.060
Why?
Aged, 80 and over
1
2017
7635
0.060
Why?
Male
8
2020
67762
0.060
Why?
Amino Acid Sequence
5
2018
2139
0.060
Why?
G1 Phase
2
1996
71
0.060
Why?
S Phase
2
1996
77
0.060
Why?
Antigens, Surface
2
2001
154
0.050
Why?
Clone Cells
2
2003
265
0.050
Why?
Cells, Cultured
1
2011
4193
0.050
Why?
Mice, SCID
2
2021
367
0.050
Why?
Liver Neoplasms, Experimental
1
2003
31
0.050
Why?
3T3 Cells
4
2003
163
0.050
Why?
Genes, erbB-2
1
2003
28
0.050
Why?
Mammary Neoplasms, Experimental
1
2003
68
0.050
Why?
Transplantation Chimera
1
2002
54
0.050
Why?
Germ Cells
1
2022
64
0.050
Why?
Molecular Conformation
1
2022
145
0.050
Why?
Middle Aged
3
2020
33479
0.050
Why?
Interleukin-2
1
2003
455
0.050
Why?
Transglutaminases
1
2022
156
0.050
Why?
Sf9 Cells
1
2021
9
0.050
Why?
Bone Marrow Cells
1
2002
316
0.040
Why?
Chimerism
1
2021
31
0.040
Why?
B7-1 Antigen
1
2001
58
0.040
Why?
Aged
2
2017
23961
0.040
Why?
Lymphocyte Subsets
1
2021
87
0.040
Why?
Lymphoid Tissue
1
2021
75
0.040
Why?
Immunoglobulins
1
2001
171
0.040
Why?
Surface Plasmon Resonance
1
2000
87
0.040
Why?
Dogs
2
2012
413
0.040
Why?
Recombinant Proteins
1
2003
1353
0.040
Why?
Alanine
1
2000
152
0.040
Why?
Mice, Inbred NOD
1
2021
601
0.040
Why?
Cyclophosphamide
2
2011
247
0.040
Why?
Paraparesis, Tropical Spastic
1
1998
3
0.040
Why?
Skin Neoplasms
1
2006
855
0.040
Why?
Gene Products, tax
1
1998
13
0.040
Why?
Models, Molecular
1
2003
1570
0.040
Why?
Gene Knockdown Techniques
1
2019
327
0.040
Why?
Lymphocytic Choriomeningitis
1
1998
19
0.040
Why?
Antibodies, Monoclonal
1
2025
1430
0.040
Why?
Receptors, Tumor Necrosis Factor, Member 25
1
2017
5
0.040
Why?
Kynurenine
1
2018
114
0.030
Why?
Combined Modality Therapy
1
2020
1236
0.030
Why?
Antigens, Viral
1
1998
178
0.030
Why?
Mice, Nude
1
2019
698
0.030
Why?
Drug Delivery Systems
1
2020
365
0.030
Why?
HLA-DRB1 Chains
1
2017
112
0.030
Why?
HLA Antigens
1
2018
240
0.030
Why?
High-Throughput Screening Assays
1
2018
158
0.030
Why?
Folic Acid Antagonists
1
1996
9
0.030
Why?
Sp1 Transcription Factor
1
1996
24
0.030
Why?
Enzyme Induction
1
1996
90
0.030
Why?
Survival Rate
1
2020
1972
0.030
Why?
Regulatory Sequences, Nucleic Acid
1
1996
91
0.030
Why?
Gene Amplification
1
1996
104
0.030
Why?
Clinical Trials as Topic
1
2020
1050
0.030
Why?
Cadaver
1
2016
296
0.030
Why?
Integrin alpha Chains
1
2014
24
0.030
Why?
Interleukin-27
1
2014
13
0.030
Why?
Toll-Like Receptor 3
1
2014
28
0.030
Why?
Poly I-C
1
2014
63
0.030
Why?
Toll-Like Receptor 7
1
2014
39
0.030
Why?
CD11b Antigen
1
2014
61
0.030
Why?
Acute Disease
1
2017
1007
0.030
Why?
DNA
3
1997
1459
0.030
Why?
Cell Division
2
1993
794
0.030
Why?
DNA Replication
1
1996
238
0.030
Why?
Cell Cycle
2
1994
601
0.030
Why?
Nuclear Proteins
2
2001
712
0.030
Why?
Culture Media, Serum-Free
1
1993
48
0.030
Why?
Imidazoles
1
2014
238
0.030
Why?
Serum Response Factor
1
1993
33
0.030
Why?
Cloning, Molecular
3
2001
534
0.020
Why?
RNA Polymerase II
1
1996
324
0.020
Why?
Phenotype
1
2021
3196
0.020
Why?
Granulocyte-Macrophage Colony-Stimulating Factor
2
2003
152
0.020
Why?
Antineoplastic Agents
1
2003
2129
0.020
Why?
Membrane Glycoproteins
1
2014
500
0.020
Why?
Antigens, Differentiation
1
2011
83
0.020
Why?
Antineoplastic Agents, Alkylating
1
2011
73
0.020
Why?
Disease Progression
1
2019
2757
0.020
Why?
CTLA-4 Antigen
1
2011
99
0.020
Why?
Follow-Up Studies
1
2020
5131
0.020
Why?
Cytokines
1
2019
2085
0.020
Why?
Von Hippel-Lindau Tumor Suppressor Protein
1
2010
16
0.020
Why?
Dimerization
2
2001
199
0.020
Why?
Proteomics
1
2018
1111
0.020
Why?
Statistics, Nonparametric
1
2011
431
0.020
Why?
Protein Biosynthesis
1
1993
433
0.020
Why?
Doxorubicin
1
2012
362
0.020
Why?
ras Proteins
1
2010
153
0.020
Why?
Analysis of Variance
1
2011
1316
0.020
Why?
Survival Analysis
1
2011
1325
0.020
Why?
DNA, Complementary
2
2001
272
0.020
Why?
Protein Binding
2
2006
2224
0.020
Why?
Vaccines, Attenuated
1
2007
132
0.020
Why?
Binding Sites
3
1997
1303
0.020
Why?
Injections, Intradermal
1
2006
13
0.020
Why?
Peptide Fragments
2
2003
706
0.020
Why?
Enterotoxins
1
2006
88
0.020
Why?
Neoplasm Transplantation
1
2006
257
0.020
Why?
Hepatitis
1
2006
48
0.020
Why?
Cell Adhesion
1
2006
466
0.010
Why?
Killer Cells, Natural
1
2007
449
0.010
Why?
Cytotoxicity Tests, Immunologic
1
2003
41
0.010
Why?
Adult
2
2017
37929
0.010
Why?
Growth Inhibitors
1
2003
43
0.010
Why?
Vaccines, DNA
1
2003
32
0.010
Why?
Peptide Mapping
1
2003
64
0.010
Why?
Cell Line, Transformed
1
2003
145
0.010
Why?
Lymphocyte Culture Test, Mixed
1
2002
50
0.010
Why?
Injections, Intravenous
1
2003
206
0.010
Why?
Mammary Neoplasms, Animal
1
2002
33
0.010
Why?
Drug Synergism
1
2003
382
0.010
Why?
Mice, Inbred DBA
1
2002
200
0.010
Why?
Adoptive Transfer
1
2003
219
0.010
Why?
Mice, Inbred Strains
1
2003
409
0.010
Why?
ZAP-70 Protein-Tyrosine Kinase
1
2001
10
0.010
Why?
Transplantation Immunology
1
2001
34
0.010
Why?
Programmed Cell Death 1 Ligand 2 Protein
1
2001
15
0.010
Why?
Transplantation, Homologous
1
2002
416
0.010
Why?
CD28 Antigens
1
2001
53
0.010
Why?
Gene Library
1
2001
118
0.010
Why?
Tumor Cells, Cultured
1
2002
955
0.010
Why?
Sequence Homology, Amino Acid
1
2001
385
0.010
Why?
Graft vs Host Disease
1
2002
252
0.010
Why?
Apoptosis Regulatory Proteins
1
2001
188
0.010
Why?
Genetic Vectors
1
2001
319
0.010
Why?
In Vitro Techniques
1
2001
1092
0.010
Why?
Image Cytometry
1
1998
8
0.010
Why?
HTLV-I Infections
1
1998
24
0.010
Why?
Human T-lymphotropic virus 1
1
1998
28
0.010
Why?
HLA-A2 Antigen
1
1998
48
0.010
Why?
Recombinant Fusion Proteins
1
2001
665
0.010
Why?
Immunity, Active
1
1998
10
0.010
Why?
Protein-Tyrosine Kinases
1
2001
434
0.010
Why?
E2F5 Transcription Factor
1
1997
3
0.010
Why?
E2F4 Transcription Factor
1
1997
8
0.010
Why?
Immunologic Memory
1
1998
353
0.010
Why?
HeLa Cells
1
1997
636
0.010
Why?
Proteins
1
2001
1009
0.010
Why?
Rats
1
2003
5647
0.010
Why?
Models, Genetic
1
1997
600
0.010
Why?
Genes
1
1994
230
0.010
Why?
Chromosome Mapping
1
1994
523
0.010
Why?
Molecular Weight
1
1992
335
0.010
Why?
Mutagenesis, Site-Directed
1
1992
375
0.010
Why?
Transfection
1
1992
945
0.000
Why?
Signal Transduction
1
2001
5079
0.000
Why?
Slansky's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)